Negative affect reported in several sexuality-related functions at two years
An oncologist discusses screening, diagnosis
New study sheds light on how long you can safely wait
Aggregating prostate cancer data improves clinical care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Molecular-based assays aid diagnosis and treatment decisions
Genomic testing isn’t just for low-risk tumors
Recipient of a Prostate Cancer Foundation Special Challenge Award
Outcomes are no worse than curative therapy over follow-up as long as 6 years
Surprisingly, no, study finds
Advertisement
Advertisement